Skip to main content

Differentially Expressed Genes Associated With Hepatitis B Virus HBx and MHBs Protein Function in Hepatocellular Carcinoma

  • Protocol
Differential Display Methods and Protocols

Part of the book series: Methods in Molecular Biology ((MIMB,volume 317))

Abstract

HBx and MHBst products from hepatitis B virus-DNA (HBV-DNA), which become transcriptional transactivators of cellular and viral genes, are known to play causative roles in the development of hepatocellular carcinoma (HCC). However, the biomolecular mechanism(s) for their roles in hepatocarcinogenesis in vivo remain poorly understood. To identify authentic cellular genes involved in HBx and MHBst-transactivated carcinogenesis, we used mRNA differential display polymerase chain reaction (DD-PCR). We examined HBx and MHBs-positive or -negative HCC, which had chromosomally integrated HBV DNA, vs nontumor tissues, respectively, and differentially expressed genes in either type of HCC were identified and compared with each other. Using 240 different combinations of three one-base anchored oligo-dT primers and 80 arbitrary 13mers, 16 genes were differentially expressed in the HBx and MHBs-positive HCC including Ro RNA hY1, glutamine synthetase, factor H homologue 3′ end, voltage-dependent anion channel 3 (VDAC3), three ribosomal proteins, four mitochondrial genes, and four novel genes. Unexpectedly, upregulated genes in association with functional HBV proteins were different from those reportedly transactivated by HBV viral proteins in vitro. Ten genes were downregulated, including three novel genes. In contrast, 15 genes in HCC tissue negative for HBx and MHBs-expression were preferentially expressed including pancreatic secretory trypsin inhibitor (PSTI), H19, guanidine nucleotide-binding protein α-1 subunit (GNAZ), carbamyl phosphate synthetase I (CPS I), insulin-like growth factor (IGF)-II, and 10 ribosomal proteins genes. Eighteen genes were downregulated including acute phase genes, a novel gene, and particularly the retinoblastoma susceptibility gene. Only two genes (ribosomal protein P0 and L37a) were commonly upregulated in both types of HCC tissues. These results suggest that cellular genes involved in the viral protein—transactivation may generally differ from those not associated with transactivation in established HCC, and that the specific oncogenic coordination through the transactivation by viral proteins which works in experiments in vitro, may play only a potential role in hepatocarcinogenesis in vivo. In addition, the functional analyses of the eight novel genes identified in this study might be valuable to further understand the mechanism(s) of hepatocarcinogenesis.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Koshy, R., Maupas, P., Müller, R., and Hofschneider, P. H. (1981) Detection of hepatitis B virus-specific DNA in the genome of human hepatocellular carcinoma and liver cirrhosis tissues. J. Gen. Virol. 57, 95–102.

    Article  PubMed  CAS  Google Scholar 

  2. Buendia, M. A. (1992) Mammalian hepatitis B virus and primary liver cancer. Semin. Cancer Biol. 3, 309–320.

    PubMed  CAS  Google Scholar 

  3. Chen, P.-J., Chen, D.-S., Lai, M.-Y., et al. (1989) Clonal origin of recurrent hepatocellular carcinoma. Gastroenterology 96, 527–529.

    PubMed  CAS  Google Scholar 

  4. Lugassy, C., Bernuau, J., Thiers, V., et al. (1987) Sequences of hepatitis B virus DNA in the serum and liver of patients with acute benign and fulminant hepatitis. J. Infect. Dis. 155, 64–71.

    PubMed  CAS  Google Scholar 

  5. Twu, J. S. and Schoemer, R. H. (1987) Transcriptional trans-activating function of hepatitis B virus. J. Virol. 61, 3448–3453.

    PubMed  CAS  Google Scholar 

  6. Spandau, D. F. and Lee, C. H. (1988) Trans-activation of viral enhancers by the hepatitis B virus X protein. J. Virol. 62, 427–434.

    PubMed  CAS  Google Scholar 

  7. Caselmann, W. H., Meyer, M., Kekule, A. S., and Lauer, U. (1990) A trans-activator function is generated by integrated of hepatitis B virus preS/S sequences in human hepatocellular carcinoma DNA. Proc. Natl. Acad. Sci. USA 87, 2970–2974.

    Article  PubMed  CAS  Google Scholar 

  8. Kekule, A. S., Lauer, U., Caselmann, W. H., Hofschneider, P. H., and Koshy, R. (1990) The preS/S region of integrated hepatitis B virus DNA encodes a transcriptional transactivator. Nature 343, 457–461.

    Article  PubMed  CAS  Google Scholar 

  9. Benn, J., Su, F., Doria, M., and Schneider, R. J. (1996) Hepatitis B virus HBx protein induces transcription factor AP-1 by activation of extracellular signal-regulated and c-Jun N-terminal mitogen-activated protein kinase. J. Virol. 70, 4978–4985.

    PubMed  CAS  Google Scholar 

  10. Seto, E., Mitchell, T. J., and Yen, T. S. (1990) Transactivation by the hepatitis B virus X protein depends on AP-2 and other transcriptional factors. Nature 344, 72–74.

    Article  PubMed  CAS  Google Scholar 

  11. Maguire, H. F., Hoffler, J. P., and Siddiqui, A. (1991) HBV X protein alters the DNA binding specificity of CREB and ATF-2 by protein-protein interaction. Science 252, 842–844.

    Article  PubMed  CAS  Google Scholar 

  12. Mahe, Y., Mukasida, N., Kuno, K., et al. (1991) Hepatitis B virus X protein transactivates human interleukin-8 gene through acting on nuclear factor κB and CCAAT/enhancer-binding protein-like cis-elements. J. Biol. Chem. 266, 13,759–13,763.

    PubMed  CAS  Google Scholar 

  13. Siddiqui, A., Gynor, R., Srinivasan, A., Mapoles, J., and Wesley-Farr, R. (1989) Trans-activation of viral enhancers including long terminal repeat of the human immunodeficiency virus by the B virus X protein. Virology 169, 479–484.

    Article  PubMed  CAS  Google Scholar 

  14. Chirillo, P., Falco, M., Puri, P. L., et al. (1999) Hepatitis B virus pX activates NF-κB-dependent transcription through a Raf-independent pathway. J. Virol. 70, 641–646.

    Google Scholar 

  15. Aufiero, B., and Schneider, R. J. (1990) The hepatitis B virus X-gene product trans-activates both RNA polymerase II and III promoters. EMBO J. 9, 497–504.

    PubMed  CAS  Google Scholar 

  16. Lara-Pezzi, E., Majano, P. L., Gomez-Gonzalo, M., et al. (1998) The hepatitis B virus X protein up-regulates tumor necrosis factor α gene expression in hepatocytes. Hepatology 28, 1013–1021.

    Article  PubMed  CAS  Google Scholar 

  17. Amaro, M. J., Bartolome, J., and Carreno, V. (1999) Hepatitis B virus X protein transactivates the inducible nitric oxide synthase promoter. Hepatology 29, 915–923.

    Article  PubMed  CAS  Google Scholar 

  18. Lauer, U., Weiss, L., Lipp, M., Hofschneider, P. H., and Kekulé, A. S. (1992) The hepatitis B virus transactivator is generated by 3′ truncation within a defined region of the S gene. J. Virol. 66, 5284–5289.

    PubMed  CAS  Google Scholar 

  19. Lauer, U., Weiss, L., Hofschneider, P. H., and Kekulé, A. S. (1994) The hepatitis B virus preS2/St transactivator utilizes AP-1 and other transcription factors for transactivation. Hepatology 19, 23–31.

    PubMed  CAS  Google Scholar 

  20. Meyer, M., Caselmann, W. H., Schluter, V., Schreck, R., Hofschneider, P. H., and Baeuerle, P. A. (1992) Hepatitis B virus transactivator MHBst: activation of NF-κB, selective inhibition by antioxidant and integral membrane localization. EMBO J. 11, 2991–3001.

    PubMed  CAS  Google Scholar 

  21. Schluter, V., Meyer, M., Hofschneider, P. H., Koshy, R., Caselmann, and W. H. (1994) Integrated hepatitis B virus X and 3′ truncated preS/S sequences derived from human hepatoma encode functionally active transactivators. Oncogene 9, 3335–3344.

    PubMed  CAS  Google Scholar 

  22. Scheuer, P. J. (1991) Classification of chronic viral hepatitis: a need for reassessment. J Hepatology 13, 372–374.

    Article  CAS  Google Scholar 

  23. Kim, D.-G., Lee, D.-Y., Cho, B.-H., You, K.-R., Kim, M.-Y., and Ahn, D.-S. (1999) Down-regulation of insulin-like growth factor binding proteins and growth modulation in hepatoma cells by retinoic acid. Hepatology 29, 1091–1098.

    Article  PubMed  CAS  Google Scholar 

  24. Liang, P. and Pardee, A.B. (1992) Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science 257, 967–971.

    Article  PubMed  CAS  Google Scholar 

  25. Liang, P., Zhu, W., Zhang, X., et al. (1994) Differential display using one-base anchored oligo-dT primers. Nucleic Acids Res. 22, 5763–5764.

    Article  PubMed  CAS  Google Scholar 

  26. Kim, M. Y., Park, E., Park, J. H., et al. (2001) Expression profile of nine novel genes differentially expressed in hepatitis B virus-associated hepatocellular carcinomas. Oncogene 20, 4568–575.

    Article  PubMed  CAS  Google Scholar 

  27. Kim, D. G., You, K. R., Liu, M. J., Choi, Y. K., Won, Y. S. (2002) GADD153-mediated anticancer effects of N-(4-hydroxyphenyl)retinamide on human hepatoma cells. J. Biol. Chem. 277, 38,930–38,938.

    Article  PubMed  CAS  Google Scholar 

  28. Kim, J. H., You, K. R., Kim, I. H. Cho, B. H., Kim, C. Y. and Kim, D. K. (2004) Over-expression of the ribosomal protein L36a (RPL36A) gene is associated with tumor cell proliferation in hepatocellular carcinoma. Hepatology 39, 129–138.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Humana Press Inc.

About this protocol

Cite this protocol

Kim, DG. (2006). Differentially Expressed Genes Associated With Hepatitis B Virus HBx and MHBs Protein Function in Hepatocellular Carcinoma. In: Liang, P., Meade, J.D., Pardee, A.B. (eds) Differential Display Methods and Protocols. Methods in Molecular Biology, vol 317. Humana Press. https://doi.org/10.1385/1-59259-968-0:141

Download citation

  • DOI: https://doi.org/10.1385/1-59259-968-0:141

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-338-1

  • Online ISBN: 978-1-59259-968-4

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics